SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001493152-23-002209
Filing Date
2023-01-23
Accepted
2023-01-23 16:42:28
Documents
12
Period of Report
2022-11-23
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-ka.htm   iXBRL 8-K/A 42723
  Complete submission text file 0001493152-23-002209.txt   221461

Data Files

Seq Description Document Type Size
2 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT invo-20221123.xsd EX-101.SCH 3245
3 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT invo-20221123_lab.xml EX-101.LAB 34916
4 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT invo-20221123_pre.xml EX-101.PRE 22801
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-ka_htm.xml XML 3756
Mailing Address 5582 BROADCAST COURT SARASOTA FL 34240
Business Address 5582 BROADCAST COURT SARASOTA FL 34240 (978) 878-9505
INVO Bioscience, Inc. (Filer) CIK: 0001417926 (see all company filings)

IRS No.: 204036208 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-39701 | Film No.: 23544954
SIC: 3841 Surgical & Medical Instruments & Apparatus